tiprankstipranks
Trending News
More News >
Evoke Pharma (EVOK)
NASDAQ:EVOK
US Market
Advertisement

Evoke Pharma (EVOK) Technical Analysis

Compare
482 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Evoke Pharma’s (EVOK) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting Evoke Pharma is a Buy.
Evoke Pharma’s (EVOK) 20-Day exponential moving average is 4.28, while Evoke Pharma’s (EVOK) share price is $4.52, making it a Buy.
Evoke Pharma’s (EVOK) 50-Day exponential moving average is 3.75, while Evoke Pharma’s (EVOK) share price is $4.52, making it a Buy.

Evoke Pharma (EVOK) Pivot Points

Jul 24, 2025, 09:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.08
4.21
4.30
4.43
4.52
4.65
4.74
Fibonacci
4.21
4.29
4.35
4.43
4.51
4.57
4.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evoke Pharma (EVOK) Moving Averages

Jul 24, 2025, 09:08 PM
Period
Simple
Exponential
MA5
4.55Sell
4.60Sell
MA10
5.06Sell
4.60Sell
MA20
4.08Buy
4.28Buy
MA50
3.55Buy
3.75Buy
MA100
3.25Buy
3.65Buy
MA200
4.07Buy
4.09Buy
Evoke Pharma’s (EVOK) 10-Day exponential moving average is 4.60, while Evoke Pharma’s (EVOK) share price is $4.52, making it a Sell.
Evoke Pharma’s (EVOK) 100-Day exponential moving average is 3.65, while Evoke Pharma’s (EVOK) share price is $4.52, making it a Buy.
Evoke Pharma’s (EVOK) stock price is $4.52 and Evoke Pharma’s (EVOK) 50-day simple moving average is 3.55, creating a Buy signal.
Evoke Pharma’s (EVOK) stock price is $4.52 and Evoke Pharma’s (EVOK) 100-day simple moving average is 3.25, creating a Buy signal.
Evoke Pharma’s (EVOK) stock price is $4.52 and Evoke Pharma’s (EVOK) 200-day simple moving average is 4.07, creating a Buy signal.

Evoke Pharma (EVOK) Technical Indicators

Jul 24, 2025, 09:08 PM
Name
Value
Implied Action
RSI (14)
55.15
Neutral
STOCH (9,6)
10.65
Buy
STOCHRSI (14)
27.17
Neutral
MACD (12,26)
0.43
Buy
ADX (14)
41.86
Neutral
Williams %R
-72.83
Buy
CCI (14)
20.92
Neutral
ATR (14)
0.64
-
Ultimate Oscillator
38.16
Neutral
ROC
68.03
Buy
Evoke Pharma’s (EVOK) Relative Strength Index (RSI) is 55.15, creating a Neutral signal.
Evoke Pharma’s (EVOK) Trend Strength Indicator (ADX) is 41.86, creating a Neutral signal.
Evoke Pharma’s (EVOK) Commodity Channel Index (CCI) is 20.92, creating a Neutral signal.
Evoke Pharma’s (EVOK) Price Rate of Change (ROC) is 68.03, creating a Buy signal.

FAQ

Is EVOK a Buy, Hold, or Sell?
Based on EVOK’s technical indicators, EVOK is a Buy.
    What is EVOK’s RSI (14)?
    EVOK’s RSI (14) is 55.15, which suggests EVOK is a Neutral.
      What is EVOK’s MACD?
      EVOK’s MACD is 0.43, which suggests EVOK is a Buy.
        What is EVOK’s 5-day moving average?
        EVOK’s 5-day moving average is 4.55, which suggests EVOK is a Sell.
          What is EVOK’s 20-day moving average?
          EVOK 20-day moving average is 4.08, which suggests EVOK is a Buy.
            What is EVOK’s 50-day moving average?
            EVOK’s 50-day moving average is 3.55, which suggests EVOK is a Buy.
              What is EVOK’s 200-day moving average?
              EVOK’s 200-day moving average is 4.07, which suggests EVOK is a Buy.
                What is EVOK’s Williams % R (14)?
                EVOK’s Williams % R (14) is -72.83, which suggests EVOK is a Buy.
                  What is EVOK’s CCI (14)?
                  EVOK’s CCI (14) is 20.92, which suggests EVOK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis